News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PARI Respiratory Equipment, Inc. Unveils New Ordering Website


1/8/2013 10:35:42 AM

MIDLOTHIAN, Va., Jan. 7, 2013 /PRNewswire/ -- PARI Respiratory Equipment welcomes 2013 by launching a customer ordering website, PARIOrder.com.

"We are pleased to serve thousands of home healthcare companies, medical supply distributors, pharmacies, hospitals, and physicians. Our customers share our commitment to providing the highest quality nebulizers and respiratory products to patients in need. PARI products, which are the most widely used in clinical trials for nebulized medications, are now conveniently available online for customers," states Geoff A. Hunziker, President of PARI in North America.

"Until now, we had not found a technology that could seamlessly connect our user-friendly and image-based catalog with our advanced Enterprise Resource Planning system. PARI Order is able to do that, while providing an easier, faster way for our customers to create, track, and view orders online," added Ashley Weigand, director of marketing.

Customers can log into www.PARIOrder.com today. Customer service representatives will also work closely to help sign up new customers and follow-up with customers over the next few weeks.

"We anticipate that everyone from individual physicians to large hospitals will appreciate the user-friendly B2B [business to business] platform that allows multiple customers to quickly place orders, track shipments, and then view accounting information as needed," concluded Weigand.

About PARI
PARI is a leading, worldwide developer and manufacturer of fast and efficient aerosol delivery systems for patients with asthma, chronic lung disease, cystic fibrosis, RSV, VAP, and HAP. PARI's worldwide vision is to improve the lives of those affected by respiratory diseases and those who care for them.

PARI is considered the gold standard for aerosol delivery for nebulizer therapies. PARI is the only nebulizer company that has demonstrated clinical success in trials for Xopenex, Brovana, DuoNeb, AccuNeb, Perforomist, TOBI, and Cayston. Featured products include the PARI LC PLUS and the drug-specific eFlow Technology platform, such as Altera that delivers Gilead Sciences' Cayston.

Additional information is available by contacting Kirsten Ayars at 805.845.5682 or Ashley Weigand at 804.253.7274 ext. 711.

SOURCE PARI Respiratory Equipment


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES